Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112670142 | 11267014 | 2 | F | 201308 | 20151017 | 20150713 | 20160707 | EXP | US-DSJP-DSU-2015-102517 | DAIICHI | 72.29 | YR | F | Y | 49.89000 | KG | 20160707 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112670142 | 11267014 | 1 | PS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/25MG, ONE TABLET DAILY | 21532 | FILM-COATED TABLET | ||||||||||
| 112670142 | 11267014 | 2 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/25MG HALF A TABLET DAILY | 21532 | FILM-COATED TABLET | ||||||||||
| 112670142 | 11267014 | 3 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 112670142 | 11267014 | 4 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | 81 MG, QD | 0 | 81 | MG | QD | ||||||||
| 112670142 | 11267014 | 5 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 100 ?G, QD | 0 | 100 | UG | QD | ||||||||
| 112670142 | 11267014 | 6 | C | COMBIGAN | BRIMONIDINE TARTRATETIMOLOL MALEATE | 1 | 0.2/0.5% ONE DROP EACH EYE 2 TIMES/DAY | 0 | |||||||||||
| 112670142 | 11267014 | 7 | C | QNASL | BECLOMETHASONE DIPROPIONATE | 1 | UNK | 0 | |||||||||||
| 112670142 | 11267014 | 8 | C | NASONEX | MOMETASONE FUROATE | 1 | UNK | 0 | |||||||||||
| 112670142 | 11267014 | 9 | C | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | UNK | 0 | |||||||||||
| 112670142 | 11267014 | 10 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 112670142 | 11267014 | 11 | C | GLUCOSAMINE | GLUCOSAMINE | 1 | 1500 MG, QD | 0 | 1500 | MG | QD | ||||||||
| 112670142 | 11267014 | 12 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | 1000 IU, QD | 0 | 1000 | IU | QD | ||||||||
| 112670142 | 11267014 | 13 | C | CALCIUM | CALCIUM | 1 | 600 IU, BID | 0 | 600 | IU | BID | ||||||||
| 112670142 | 11267014 | 14 | C | SUDAFED | PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 112670142 | 11267014 | 15 | C | MEDROL | METHYLPREDNISOLONE | 1 | UNK | 0 | |||||||||||
| 112670142 | 11267014 | 16 | C | IMODIUM | LOPERAMIDE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 112670142 | 11267014 | 17 | C | PEPTO-BISMOL | BISMUTH SUBSALICYLATE | 1 | UNK | 0 | |||||||||||
| 112670142 | 11267014 | 18 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | UNK | 0 | |||||||||||
| 112670142 | 11267014 | 19 | C | MULTI-VITAMINS VITAFIT | 2 | ONE DAILY | 0 | ||||||||||||
| 112670142 | 11267014 | 20 | C | PREVACID | LANSOPRAZOLE | 1 | 30 MG, QD | 0 | 30 | MG | QD | ||||||||
| 112670142 | 11267014 | 21 | C | LASIX | FUROSEMIDE | 1 | 40 MG, 1/2 TABLET DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112670142 | 11267014 | 1 | Hypertension |
| 112670142 | 11267014 | 3 | Product used for unknown indication |
| 112670142 | 11267014 | 4 | Product used for unknown indication |
| 112670142 | 11267014 | 5 | Product used for unknown indication |
| 112670142 | 11267014 | 6 | Product used for unknown indication |
| 112670142 | 11267014 | 7 | Product used for unknown indication |
| 112670142 | 11267014 | 8 | Product used for unknown indication |
| 112670142 | 11267014 | 9 | Product used for unknown indication |
| 112670142 | 11267014 | 10 | Product used for unknown indication |
| 112670142 | 11267014 | 11 | Product used for unknown indication |
| 112670142 | 11267014 | 12 | Product used for unknown indication |
| 112670142 | 11267014 | 13 | Product used for unknown indication |
| 112670142 | 11267014 | 14 | Product used for unknown indication |
| 112670142 | 11267014 | 15 | Product used for unknown indication |
| 112670142 | 11267014 | 16 | Product used for unknown indication |
| 112670142 | 11267014 | 17 | Product used for unknown indication |
| 112670142 | 11267014 | 18 | Product used for unknown indication |
| 112670142 | 11267014 | 19 | Product used for unknown indication |
| 112670142 | 11267014 | 20 | Product used for unknown indication |
| 112670142 | 11267014 | 21 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112670142 | 11267014 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112670142 | 11267014 | Acidosis | |
| 112670142 | 11267014 | Anal incontinence | |
| 112670142 | 11267014 | Asthenia | |
| 112670142 | 11267014 | Gastrointestinal disorder | |
| 112670142 | 11267014 | Gastrointestinal injury | |
| 112670142 | 11267014 | Hyperplasia | |
| 112670142 | 11267014 | Ileal stenosis | |
| 112670142 | 11267014 | Intestinal mass | |
| 112670142 | 11267014 | Intestinal villi atrophy | |
| 112670142 | 11267014 | Malabsorption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112670142 | 11267014 | 1 | 20090429 | 20120821 | 0 | |
| 112670142 | 11267014 | 2 | 20120821 | 20131231 | 0 | |
| 112670142 | 11267014 | 3 | 201312 | 0 | ||
| 112670142 | 11267014 | 6 | 2010 | 0 | ||
| 112670142 | 11267014 | 10 | 20131126 | 20140208 | 0 | |
| 112670142 | 11267014 | 11 | 201312 | 0 | ||
| 112670142 | 11267014 | 12 | 200910 | 0 | ||
| 112670142 | 11267014 | 13 | 200910 | 0 | ||
| 112670142 | 11267014 | 18 | 20131231 | 0 | ||
| 112670142 | 11267014 | 20 | 201312 | 0 | ||
| 112670142 | 11267014 | 21 | 201402 | 0 |